Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-23
2007-10-23
Tucker, Zachary C (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
10472626
ABSTRACT:
A pharmaceutical composition for prevention and/or treatment for HIV infection or AIDS induced by the infection which comprises, as an active ingredient, a triazaspiro[5.5]undecane derivative, a quaternary ammonium salt thereof, an N-oxide thereof, or a non-toxic salt thereof, and if necessary, it may be combined with at least one member of other agents for prevention and/or treatment for HIV infection (wherein all symbols are as defined in the specification.)The triazaspiro[5.5]undecane derivatives, the quaternary ammonium salts thereof or the N-oxides thereof, or the non-toxic salts thereof are useful in preventing and/or treating HIV infection and AIDS induced by the infection.
REFERENCES:
patent: 6288083 (2001-09-01), Luly et al.
patent: 6288084 (2001-09-01), Luly et al.
patent: 7053090 (2006-05-01), Habashita et al.
patent: 7119091 (2006-10-01), Habashita et al.
patent: 2005/0215557 (2005-09-01), Habashita et al.
patent: 1 123 726 (2002-09-01), None
patent: 2 127 807 (1984-04-01), None
patent: 59-89671 (1984-05-01), None
patent: WO93-13101 (1993-07-01), None
patent: WO97-11940 (1997-04-01), None
patent: WO 01/40227 (2001-06-01), None
Liu et al, “Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection” Cell, vol. 86, pp. 367-377 (1996).
Samson et al, “Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene” Nature, vol. 382, pp. 722-725 (1996).
Maeda, K. et al., “Novel Low Molecular Weight Spirodiketopiperazin Derivatives Potently Inhibit R5HIV-1 Infection through Their Antagonistic Effects on CCR5”, Journal of Biological Chemistry, 276 (37), pp. 35194 to 35200 (2001).
Maeda Kenji
Mitsuya Hiroaki
Shibayama Shiro
Takaoka Yoshikazu
Ono Pharmaceuticals Co. Ltd.
Sughrue Mion Pllc.
Tucker Zachary C
LandOfFree
Drugs containing triazaspiro[5.5]undecane derivatives as the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drugs containing triazaspiro[5.5]undecane derivatives as the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs containing triazaspiro[5.5]undecane derivatives as the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3847032